Literature DB >> 11223919

Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats.

M Rancan1, V I Otto, V H Hans, I Gerlach, R Jork, O Trentz, T Kossmann, M C Morganti-Kossmann.   

Abstract

The pathophysiology of traumatic axonal injury (TAI) is only partially understood. In this study, we investigated the inflammatory response as well as the extent of neurological deficit in a rat model of traumatic brain injury (TBI). Forty-two adult rats were subjected to moderate impact-acceleration brain injury and their brains were analyzed immunohistochemically for ICAM-1 expression and neutrophil infiltration from 1 hr up to 14 days after trauma. In addition, the chemotactic factors MIP-2 and MCP-1 were measured in brain homogenates by ELISA. For evaluating the neurological deficit, three sensorimotor tests were applied for the first time in this model. In the first 24 hr after trauma, the number of ICAM-1 positive vessels increased up to 4-fold in cortical and subcortical regions compared with sham operated controls (P < 0.05). Maximal ICAM-1 expression (up to 8-fold increase) was detected after 4 days (P < 0.001 vs. 24 hr), returning to control levels in all brain regions by 7 days after trauma. MCP-1 was elevated between 4 hr and 16 hr post-injury as compared with controls. In contrast, neither neutrophil infiltration nor elevation of MIP-2, both events relevant in focal brain injury, could be detected. In all neurological tests, a significant deficit was observed in traumatized rats as compared with sham operated animals from Day 1 post-injury (grasping reflex of the hindpaws: P < 0.001, vibrissae-evoked forelimb placing: P = 0.002, lateral stepping: P = 0.037). In conclusion, after moderate impact acceleration brain injury ICAM-1 upregulation has been demonstrated in the absence of neutrophil infiltration and is paralleled by a selective induction of chemokines, pointing out that individual and distinct inflammatory events occur after diffuse vs. focal TBI. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223919     DOI: 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  35 in total

Review 1.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

2.  CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.

Authors:  Josh M Morganti; Timothy D Jopson; Sharon Liu; Lara-Kirstie Riparip; Cristian K Guandique; Nalin Gupta; Adam R Ferguson; Susanna Rosi
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 3.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice.

Authors:  Bridgette D Semple; Nicole Bye; Mario Rancan; Jenna M Ziebell; M Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-23       Impact factor: 6.200

5.  Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury.

Authors:  Hong-Cai Wang; Bo-Ding Wang; Mao-Song Chen; Hai Chen; Cheng-Feng Sun; Gang Shen; Jian-Min Zhang
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

6.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

Review 7.  Chemokines and pain mechanisms.

Authors:  Catherine Abbadie; Sonia Bhangoo; Yves De Koninck; Marzia Malcangio; Stéphane Melik-Parsadaniantz; Fletcher A White
Journal:  Brain Res Rev       Date:  2008-12-25

Review 8.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

9.  Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver.

Authors:  Sandra J Campbell; V Hugh Perry; Fernando J Pitossi; Angus G Butchart; Mariela Chertoff; Sara Waters; Robert Dempster; Daniel C Anthony
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

10.  Anti-edema effect of Aloe vera leaf extract following traumatic brain injury: Role of pro-inflammatory cytokines.

Authors:  Marzieh Shahryari; Bahram Bibak; Mohammad Khaksari; Zakieh Keshavarzi; Neda Salmani; Sara Shirazpour; Fatemeh Alimahdi
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.